Showing results (621-630 of 3,697) with videos related to
Sort By:
Pageof 370
International Journal of Clinical Oncology|October 30, 2020
Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2)Tomoya Yokota, Yosuke Ota, Hirofumi Fujii, et al.International Journal of Clinical Oncology|June 8, 2021
On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinomaKimiharu Takamatsu, Ryuichi Mizuno, Yuto Baba, et al.International Journal of Clinical Oncology|June 10, 2021
Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillanceMakoto Tahara, Naomi Kiyota, Ken-Ichi Nibu, et al.International Journal of Clinical Oncology|February 4, 2016
Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratioYoung Woo Chang, Hwan Soo Kim, Seung Pil Jung, et al.International Journal of Clinical Oncology|January 10, 2016
S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)Yuji Miyamoto, Akihito Tsuji, Hiroaki Tanioka, et al.International Journal of Clinical Oncology|January 14, 2016
Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in JapanArata Tsutsumida, Akira Takahashi, Kenjiro Namikawa, et al.International Journal of Clinical Oncology|December 24, 2015
Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinomaMasahiro Nozawa, Koichi Sugimoto, Takayuki Ohzeki, et al.International Journal of Clinical Oncology|December 25, 2015
Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot studyNorio Itokawa, Masanori Atsukawa, Akihito Tsubota, et al.International Journal of Clinical Oncology|February 10, 2016
Prognostic significance of NADPH oxidase-4 as an indicator of reactive oxygen species stress in human retinoblastomaLata Singh, Neeru Saini, Neelam Pushker, et al.International Journal of Clinical Oncology|September 24, 2015
Is scintigraphy necessary to detect migration of 125I seeds after brachytherapy for early prostate cancer?Yu Odagaki, Makoto Ohori, Mana Yoshimura, et al.Pageof 370